Date post: | 07-May-2015 |
Category: |
Health & Medicine |
Upload: | randox |
View: | 1,173 times |
Download: | 8 times |
“revolutionising healthcare through continuously improving diagnostic solutions”
RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME
• The worlds largest global EQA scheme in the world – Large database of users – 22 flexible EQA programmes– Accredited to ISO/IEC 17043:2010– Comprehensive yet user friendly reports – Highest quality materials– Regular reporting (Bi-weekly/Monthly)– Rapid report turnaround (1-3 days from final submission date)– Consolidation – reduce the number of programmes required– Flexible options available to suit all laboratory sizes and budgets– Register up to 5 separate instruments at no extra cost and receive complimentary multi-
instrument report – Free interlaboratory report available to lab chains or groups– Certificates of participation provided at the end of each cycle– End-of-cycle reports provided – Submit results and view reports online via RIQAS.Net
The World’s Largest Global EQA Scheme
Over 24, 000 laboratory participants
More than 105 countries worldwide
Larger peer groups more statistically relevant data
Wider range of instruments and methods covered
22 Flexible EQA Programmes• BNP• Clinical Chemistry • Immunoassay • Specific Proteins• Liquid Cardiac • Cardiac• Coagulation • Blood Gas• Urinalysis• Maternal Screening• Lipids
• Urine Toxicology• Human Urine• HbA1c • Immunoassay Speciality I • Immunoassay Speciality II • Haematology • Therapeutic Drugs • Serology EBV• Serology HIV/Hepatitis• Serology ToRCH• Serology Syphilis
Internationally Accredited
• RIQAS is internationally accredited to the following standards– ISO/IEC 17043:2010– ISO 13485– UKAS– UK National Quality Assurance Advisory Panel
(NQAAP)– Joint Working Group on Quality Assurance
(JWQ QA)
User Friendly Reports• RIQAS reports are presented in a convenient one page per
parameter format with the following features:– Compare results to all methods, method group and instrument group – Compare to RIQAS default limits or user defined limits e.g. CLIA or
Biological variation – Levey-Jennings charts displaying results for last 20 samples– Unique target score chart allowing at a glance assessment – % deviation by concentration chart for rapid assessment of concentration
related bias– Histogram charts comparing performance to peers, all methods, method
group and instrument group can be viewed on one chart– Multi-method stat section allows you to assess the performance of other
methods – Summary page conveniently highlighting any poor performing tests at a
glance
Standard RIQAS Report
Summary Page
Parameter Report
End-of Cycle Reports
• End-of-cycle reports– Provided at the end of each cycle and contain a
summary of all statistics – Compare performance to the previous cycle– Compare to laboratories worldwide or in your
country only – Text and graphical representation– Certificate of performance listing all parameters for
which your lab achieved acceptable performance provided
End-of-Cycle Reports
Multi-Instrument Reports
• Laboratories can register up 5 instruments for each parameter at no extra cost – Individual reports for each instrument are
supplied in addition to a complimentary unique multi-instrument report
– Allows comparative performance assessment of each instrument
Interlaboratory Reports
• Ideal for laboratory groups and chains
• Allows comparative performance assessment of multiple connected laboratories
• Available at no extra cost to participating laboratories
Highest Quality Samples
• All RIQAS samples are designed to mirror the performance of patient samples – 100% human samples for immunoassay methods– Free from interfering preservatives/stabilisers– Covers a range of concentrations
Frequent Reporting
• RIQAS offers monthly or bi-weekly reporting – Identify system errors sooner – Cover a range of clinically significant
concentrations sooner – Allows laboratories to take corrective and
preventative actions sooner with minimum disruption to laboratory output
– Can be used to complement national EQA schemes
RIQAS Clinical Chemistry Programme• Designed to monitor the performance of 50 parameters including routine
chemistries, lipids, hormones and trace metals
• Contains routinely run thyroid hormones in addition to PSA meaning it can even be used by small labs to cover their full immunoassay menu
• Three flexible yet cost effective programme options available– Choose any 10 parameters– Choose any 17 parameters– Choose all 50 parameters
• Bi-weekly reporting
• Reference method values available for 12 parameters
RIQAS Immunoassay Programme • Designed to monitor up to 55 parameters including therapeutic
drugs, hormones, tumour markers and Vitamin D
• 4 flexible yet cost effective programme options available – Choose any 4 parameters– Choose any 13 parameters– Choose all 55 parameters– Choose all 55 parameters (monthly reporting)
• Choice of bi-weekly or monthly reporting
• 100% human samples
Immunoassay Speciality I + II • Immunoassay Speciality I
– Designed to monitor 10 specialised immunoassay parameters including Procalcitonin and Vitamin D
– 100% human serum – Monthly reporting
• Immunoassay Speciality II– Designed to monitor 5 complex, specialised immunoassay parameters – 100% human serum – Monthly reporting
Only EQA scheme to offer Procalcitonin
Haematology Programme • Designed to monitor the performance of 12 haematology
parameters
• Liquid ready-to-use samples for ease of use and convenience
• 100% whole blood samples
• Samples provided in primary tubes for convenience
• Bi-weekly reporting
Serology Programmes • 4 serology programmes
– Epstein Barr Virus (3 parameters)– HIV/Hepatitis (10 parameters)– ToRCH (12 parameters)– Syphilis
• Liquid ready to use samples for ease of use and convenience
• Quarterly reporting
• Free from interfering infectious components
• Large database of users• 22 flexible EQA programmes• Accredited to ISO/IEC 17043:2010• Comprehensive yet user friendly reports • Highest quality materials• Regular reporting (Bi-weekly/Monthly)• Rapid report turnaround (1-3 days from final submission date)• Consolidation – reduce the number of programmes required• Flexible options available to suit all laboratory sizes and budgets• Register up to 5 separate instruments at no extra cost and receive
complimentary multi-instrument report • Free interlaboratory report available to lab chains or groups• Certificates of participation provided at the end of each cycle• End-of-cycle reports provided • Submit results and view reports online via RIQAS.Net
Summary
“revolutionising healthcare through continuously improving diagnostic solutions”